Molecule Details
InChIKeyDWZCDSLYZDTWQH-JCUPRAGWSA-N
Compound NameN-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]-6-{[2-(isoquinoline-5-sulfonamido)ethyl]amino}hexanamide
Canonical SMILESN=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12)C(N)=O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)5
Pfam Stratification Homologous
Avg pChEMBL7.8
SourceChEMBL
2D Structure
2D structure
Activity Profile
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
O75116 ROCK2 Homo sapiens Human PF25346 PF00069 PF08912 8.6 IC50 ChEMBL
P23443 RPS6KB1 Homo sapiens Human PF00069 PF00433 8.2 IC50 ChEMBL
Q13976 PRKG1 Homo sapiens Human PF00027 PF16808 PF00069 7.6 IC50 ChEMBL
O75582 RPS6KA5 Homo sapiens Human PF00069 PF00433 7.3 IC50 ChEMBL
Q9Y243 AKT3 Homo sapiens Human PF00169 PF00069 PF00433 7.2 IC50 ChEMBL